Leonard Rickey Investment Advisors’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,459
Closed -$9.63K 116
2024
Q2
$9.63K Sell
1,459
-177
-11% -$1.2K ﹤0.01% 108
2024
Q1
$18K Buy
+1,636
New +$17.7K ﹤0.01% 93
2023
Q1
Sell
-131
Closed -$4.3K 72
2022
Q4
$4.3K Buy
131
+24
+22% +$1.75K ﹤0.01% 67
2022
Q3
$13K Buy
107
+7
+7% +$1.26K 0.01% 59
2022
Q2
$18K Buy
100
+4
+4% +$843 0.01% 66
2022
Q1
$28K Hold
96
0.01% 69
2021
Q4
$50K Buy
96
+9
+10% +$6.46K 0.02% 73
2021
Q3
$33K Buy
87
+4
+5% +$1.72K 0.01% 70
2021
Q2
$54K Hold
83
0.02% 73
2021
Q1
$99K Sell
83
-4
-5% -$5.51K 0.04% 65
2020
Q4
$116K Buy
+87
New +$128K 0.05% 64

Other funds holding BIOR

Leonard Rickey Investment Advisors's BIOR Position: Q3 2024 in Review

Leonard Rickey Investment Advisors sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2024, closing a stake of 1,459 shares — an estimated $9.63K sold.

Leonard Rickey Investment Advisors first reported a position in BIOR in Q4 2020 and held it in 11 quarters. The position peaked at $116K in Q4 2020. 20 funds tracked by Wall St. Rank hold BIOR as of Q3 2024.

  • Leonard Rickey Investment Advisors reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Leonard Rickey Investment Advisors sold 1,459 Biora Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $9.63K.
  • Leonard Rickey Investment Advisors first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Leonard Rickey Investment Advisors's Biora Therapeutics, Inc. Common Stock position peaked at $116K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Leonard Rickey Investment Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.